Supernus Pharmaceuticals, Inc.
STABILIZED FORMULATIONS OF CNS COMPOUNDS
Last updated:
Abstract:
Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2021
Issue date:
21 Oct 2021